series-c-plus
Stage
1
Investors
About
Halozyme Therapeutics develops drug delivery technologies, including ENHANZE®, that improve the administration and effectiveness of therapeutics to enhance patient outcomes.
Explore Halozyme Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.